A multiplex PCR panel kit for acute leukaemia diagnostics. Designed for comprehensive detection of multiple mutations and markers associated with acute leukaemias.
Manufactured by
TRUPCR Europe Ltd
Manchester, United Kingdom
TRUPCR Europe Ltd appears to be a technology company with an online presence at trupcr.com. Based on their website, they maintain digital operations that require secure connections and cookie-enabled browsing for optimal functionality. The company serves users through their web platform, prioritizing site security and proper browser configuration for seamless access.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 9 relevant products
Zeesan Biotech Co., Ltd
China · 1 relevant product
BIOTYPE GmbH
Germany · 5 relevant products
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 88 closest product alternatives
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Comprehensive PCR panel for detecting recurrent mutations and translocations in acute leukemia. Enables simultaneous screening of multiple markers for diagnosis and classification.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Targeted diagnostic panel for detecting mutations and fusion genes in acute lymphoblastic leukemia. Supports prognostic stratification and identification of therapeutic targets.
Zeesan Biotech Co., Ltd · China
Molecular diagnostic kit for screening leukemia-associated fusion genes using nucleic acid analysis. Enables detection of chromosomal abnormalities in blood and bone marrow samples to support leukemia diagnosis and classification. Utilizes advanced molecular techniques to identify clinically relevant fusion gene targets.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products